F8 and hemophilia A: When bleeding rates among adults/adolescents with hemophilia A (with or without FVIII inhibitors) and children with FVIII inhibitors were investigated in an observational, noninterventional study (NIS),6, 7, 8 the Bleed and Medication Questionnaire (BMQ), which requires patients to record bleeds independent of treatment, was implemented to facilitate prospective data collection on both untreated and treated bleeds.